Stockscreener 앱 받기
20.94
2.21%
-0.50
전일 마감가:
$21.44
열려 있는:
$21.29
하루 거래량:
210.33K
Relative Volume:
0.13
시가총액:
$1.89B
수익:
$1.13B
순이익/손실:
$62.75M
주가수익비율:
33.24
EPS:
0.63
순현금흐름:
$170.92M
1주 성능:
-5.04%
1개월 성능:
-4.09%
6개월 성능:
+28.24%
1년 성능:
-35.88%
1일 변동 폭
$20.73
$21.40
1주일 범위
$20.63
$22.28
52주 변동 폭
$13.39
$33.84
Progyny Inc Stock (PGNY) Company Profile
명칭
Progyny Inc
전화
212-888-3124
주소
1359 BROADWAY, NEW YORK, NY
PGNY을(를) 다른 주식과 비교
| 주식 | 가격 | 시가총액 | 매출 | 순이익 | 현금흐름 | 주당 순 이익 |
|---|---|---|---|---|---|---|
PGNY
Progyny Inc
|
20.94 | 1.89B | 1.13B | 62.75M | 170.92M | 0.63 |
|
UNH
Unitedhealth Group Inc
|
432.61 | 548.34B | 410.06B | 22.11B | 24.86B | 23.88 |
|
ELV
Elevance Health Inc
|
405.29 | 99.88B | 176.81B | 5.98B | 4.55B | 25.61 |
|
CI
Cigna Group
|
323.90 | 89.25B | 244.38B | 3.43B | 8.96B | 12.24 |
|
CVS
Cvs Health Corp
|
64.63 | 87.36B | 372.81B | 4.61B | 6.33B | 3.66 |
|
HUM
Humana Inc
|
244.79 | 34.38B | 117.76B | 1.21B | 2.39B | 9.95 |
Progyny Inc Stock (PGNY) Upgrades & Downgrades
| 날짜 | 액션 | 분석자 | 등급 변경 |
|---|---|---|---|
| 2024-12-02 | 다운그레이드 | JP Morgan | Overweight → Neutral |
| 2024-11-13 | 다운그레이드 | Truist | Buy → Hold |
| 2024-09-19 | 다운그레이드 | JMP Securities | Mkt Outperform → Mkt Perform |
| 2024-08-07 | 다운그레이드 | BTIG Research | Buy → Neutral |
| 2024-08-07 | 다운그레이드 | Canaccord Genuity | Buy → Hold |
| 2024-08-07 | 다운그레이드 | Leerink Partners | Outperform → Market Perform |
| 2024-07-16 | 개시 | JMP Securities | Mkt Outperform |
| 2024-05-10 | 다운그레이드 | KeyBanc Capital Markets | Overweight → Sector Weight |
| 2024-02-26 | 개시 | Leerink Partners | Outperform |
| 2024-01-03 | 개시 | Barclays | Overweight |
| 2023-09-27 | 개시 | Canaccord Genuity | Buy |
| 2023-05-22 | 개시 | BTIG Research | Buy |
| 2023-04-21 | 개시 | Cantor Fitzgerald | Overweight |
| 2023-01-05 | 다운그레이드 | SVB Leerink | Outperform → Mkt Perform |
| 2022-09-16 | 개시 | KeyBanc Capital Markets | Overweight |
| 2022-09-07 | 개시 | Truist | Buy |
| 2021-12-02 | 개시 | Jefferies | Buy |
| 2021-11-22 | 다운그레이드 | Citigroup | Buy → Neutral |
| 2021-09-30 | 개시 | Berenberg | Buy |
| 2021-08-12 | 개시 | Barclays | Overweight |
| 2021-06-02 | 다운그레이드 | Guggenheim | Buy → Neutral |
| 2021-04-29 | 재개 | JP Morgan | Overweight |
| 2021-03-10 | 업그레이드 | BofA Securities | Neutral → Buy |
| 2020-07-01 | 개시 | SVB Leerink | Outperform |
| 2020-06-02 | 개시 | Guggenheim | Buy |
| 2019-11-19 | 개시 | Citigroup | Buy |
| 2019-11-19 | 개시 | Goldman | Buy |
| 2019-11-19 | 개시 | JP Morgan | Overweight |
| 2019-11-19 | 개시 | Piper Jaffray | Overweight |
| 2019-11-19 | 개시 | SVB Leerink | Outperform |
모두보기
Progyny Inc 주식(PGNY)의 최신 뉴스
Progyny Rings the Opening Bell - Nasdaq
Progyny names Melissa Cummings as COO - MSN
Returns Are Gaining Momentum At Progyny (NASDAQ:PGNY) - Yahoo Finance
Progyny names new COO and CPO to drive growth By Investing.com - Investing.com India
Progyny (PGNY) Boosts Leadership Team with COO and Chief Product Officer Appointments | PGNY Stock News - GuruFocus
Progyny Names Melissa Cummings COO - marketscreener.com
Progyny names new COO and CPO to drive growth - Investing.com
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer | PGNY Stock News - GuruFocus
Progyny Names Healthcare Veterans Melissa Cummings as Chief - GlobeNewswire
Progyny Names Healthcare Veterans Melissa Cummings as Chief Operating Officer and Geoffrey Clapp as Chief Product Officer - Yahoo
Progyny to Host Events Honoring Individuals, Families and Infert - GuruFocus
Progyny to Host Events Honoring Individuals, Families and - GlobeNewswire
Progyny Takes Over Nasdaq & Empire State Building for Groundbreaking Fertility Awareness Week - Stock Titan
Progyny announces director Dr. Fred Cohen to step down By Investing.com - Investing.com Canada
Form DEFA14A Progyny, Inc. - StreetInsider
Progyny announces director Dr. Fred Cohen to step down - Investing.com Australia
Progyny Director Fred Cohen to Step Down - TipRanks
SEC Form DEFA14A filed by Progyny Inc. - Quantisnow
Progyny, Inc. Announces Fred E. Cohen Notifies the Board of Directors of His Decision Not to Stand for Reelection At the 2025 Annual Meeting of Stockholders - marketscreener.com
Assisted Reproductive Technology Market Forecast Report and Company Analysis 2025-2033 Featuring Thermo Fisher Scientific, Sumitomo Mitsui, CooperSurgical, Fujifilm, Merck, Progyny, Cosmos BiomedicalResearchAndMarkets.com - Bluefield Daily Telegraph
The Broken Brown Egg and Progyny Announce the 2025 Awareness, Hope, and Activism Grant™ to Support BIPOC Individuals and Couples in Family Building - The Manila Times
The Broken Brown Egg and Progyny Announce the 2025 - GlobeNewswire
Major Fertility Support: Progyny's New Grant Removes Barriers for BIPOC Family Building - Stock Titan
Progyny's SWOT analysis: fertility benefits provider faces growth hurdles - Investing.com
Progyny, Inc.'s (NASDAQ:PGNY) Stock's On An Uptrend: Are Strong Financials Guiding The Market? - simplywall.st
Progyny (PGNY): Buy, Sell, or Hold Post Q4 Earnings? - Yahoo Finance
Progyny, Inc. Reports Strong 2024 Earnings with Optimistic Outlook - MSN
BTIG Upgrades Progyny (PGNY) - Nasdaq
Progyny expands maternal health offerings with doula services By Investing.com - Investing.com South Africa
Analyst Expectations For Progyny's Future - Benzinga
Progyny expands maternal health offerings with doula services - Investing.com India
Progyny expands materna health support with doula services - TipRanks
BTIG lifts Progyny stock rating to Buy, sets $28 target By Investing.com - Investing.com Canada
Progyny Expands Maternal Health Support with Addition of Doula Services - The Manila Times
BTIG lifts Progyny stock rating to Buy, sets $28 target - Investing.com Australia
BTIG Upgrades Progyny to Buy From Neutral, Price Target is $28 - marketscreener.com
BTIG upgrades Progyny to Buy on improving demand - TipRanks
The past three years for Progyny (NASDAQ:PGNY) investors has not been profitable - Yahoo Finance
Commit To Buy Progyny At $17.50, Earn 12.7% Annualized Using Options - Nasdaq
James Hardie Industries, MINISO Group And Other Big Stocks Moving Lower In Monday's Pre-Market Session - Benzinga
Progyny Clears Key Benchmark, Hitting 80-Plus RS Rating - MSN
The three-year loss for Progyny (NASDAQ:PGNY) shareholders likely driven by its shrinking earnings - simplywall.st
Progyny at KeyBanc Forum: Strategic Growth and Challenges By Investing.com - Investing.com UK
How the (PGNY) price action is used to our Advantage - Stock Traders Daily
Progyny Expands Family Building Solutions with New Parent and Child Well-being Offering - GlobeNewswire
Progyny launches Parent and Child Well-being Offering - TipRanks
Progyny Tackles 40% of Workforce Needs with Game-Changing Parent Support Solution - StockTitan
Mutual of America Capital Management LLC Has $194,000 Stock Position in Progyny, Inc. (NASDAQ:PGNY) - Defense World
Progyny at Leerink’s Global Healthcare Conference: Strategic Expansion Focus By Investing.com - Investing.com Canada
Progyny, Inc. to Participate in Upcoming Investor Conferences - The Manila Times
Exclusive Access: Progyny Leadership Reveals Growth Strategy at Triple Healthcare Conference Series - StockTitan
Progyny Inc (PGNY) 재무 분석
매출
순이익
현금흐름
주당 순 이익
1.33%
자본화:
|
볼륨(24시간):